stars 1 stars 2 stars 3

Designs and manufactures advanced technology for hemostasis, specifically advanced blood clotting technology. NexStat Topical Hemostat Powder is intended for use under the care of a health care professional as a topical dressing for the temporary treatment of moderate to severely bleeding wounds such as surgical wounds (post-operative, donor sites, dermatological), cuts and lacerations and for the treatment of mild bleeding from topical ENT surgical wounds and nosebleeds. It is also indicated for control of bleeding from the skin at percutaneous needle access, vascular and percutaneous catheter access sites. NexFoam is a versatile sponge that can be used as a spacer, stent and hemostat. It dissolves naturally over 7-14 days or can be easily removed with gentle irrigation. Both NexStat and NexFoam are biocompatible and require no special storage conditions.

Hemostasis, LLC Questions

The Hemostasis, LLC annual revenue was $5.9 million in 2026.

Keith Roberts is the CEO of Hemostasis, LLC.

28 people are employed at Hemostasis, LLC.

Hemostasis, LLC is based in Saint Paul, Minnesota.

The NAICS codes for Hemostasis, LLC are [33, 339].

The SIC codes for Hemostasis, LLC are [38, 384].

Top Hemostasis, LLC Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users